Global P O C Molecular Diagnostic Market Overview
P-o-c Molecular Diagnostic Market is broadly used to diagnose and monitor various diseases, detect risks, and to identify beneficial treatment for patients. In simple terms, molecular diagnostics is a process to identify a disease by studying molecules, such as DNA, RNA, and proteins, in a tissue or fluid. For many years, molecular diagnostics has been conducted in centralized laboratories. However, it has few drawbacks like the high cost of tests, delay in results, late disease diagnosis, and less accuracy are resulting in to an increase in mortality rate. Thus, limiting the growth of this market. Therefore, to overwhelm this, the new technique called a point of care molecular diagnostics has emerged. This technique has the ability to provide accurate and rapid results in less than 1-2 hours has helped to surge its adoption in various low-resource settings. The global p-o-c molecular diagnostic market accounted for US$ 1.7 billion in 2019 and is estimated to be US$ 6.7 billion by 2029 and is anticipated to register a CAGR of 14.8%.
Impact of Covid-19 pandemic on market
The outbreak of COVID-19 has raised the demand for a number of kits and rapid tests. As screening is being performed at a massive scale during this outbreak hotspot. There is a high demand for Covid-19 screening as a crucial factor for revenue growth in this market space. This report will quantify the impact of this pandemic on the p-o-c molecular diagnostic market.
Global P O C Molecular Diagnostic Market Dynamics
Growing cases of chronic diseases associated with the aging population
Increase in the prevalence of various chronic diseases among the number of aged people is continuously increasing over several decades. For instance, according to the International Journal of Cancer, the number of new cancer cases was 14.1 million in 2012 in the world, which is projected to raise up to 24.4 million by 2035 with China witnessing the maximum number of cancer cases among 65 years and older. This is attributed to the growing number of cancer risk factors, lack of detection & treatment solutions, and lack of information about their causes.
Technological advancements
Ongoing research and development are continually funded and supported by a number of major international bodies involving the governments of established countries which is the major factor expected to reinforce the high growth potential for POC molecular diagnostics products. Furthermore, recent advances in the genetic sequencing instrumentation and development of microfluidics pave the way for the development of highly accurate, cost-effective, and rapid testing platforms, which are able to be used as true POC systems.
However, stringent rules and regulations and lack of reimbursement policies coupled with rising procedure costs act as a limiting factors for the point of care molecular diagnostics market over the forecast period.
Global P O C Molecular Diagnostic Market Segmentation
The global p-o-c molecular diagnostic market is segmented based on product & solution, technology, application, end-user, and region.
On the basis of product & solution, the global p-o-c molecular diagnostic market is segmented into kits & assays, analyzers, and software & services. On the basis of technology, the target market is segmented into PCR-based, genetic sequencing-based, hybridization-based, and microarray-based. Based on application, the target market is segmented into respiratory diseases, sexually transmitted diseases (STDs), hospital-acquired infections (HAIs), cancer/oncology, prenatal/neonatal testing, and other applications. Based on end-user, the target market is segmented into clinics and diagnostic laboratories, hospital outpatient departments, and intensive care units (ICUs), research and academic institutes, and other end users.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
In the region, the global p-o-c molecular diagnostic market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the highest region in terms of revenue share owing to the availability of technologically advanced medical framework, huge R&D investments by governments, and private organizations for the development of POC MDx tests. Asia Pacific region is projected to grow at the fastest CAGR in the mentioned forecast period due to rising incidences of chronic diseases associated with the geriatric population. Additionally, expansion of key market players in this region, potential cost-effectiveness of POC molecular diagnosis, and insufficient sophisticated central laboratory testing services.
|
Attribute |
Details |
|
The base year for estimation |
2019 |
|
Forecast period |
2019 – 2029 |
|
Market representation |
Revenue in USD Million & CAGR from 2019 – 2029 |
|
Market Segmentation |
By Product & Solution- Kits & Assays, Analyzers, and Software & Services By Technology– PCR-based, Genetic Sequencing-based, Hybridization-based, and Microarray-based By Application– Respiratory Diseases, Sexually Transmitted Diseases (STDs), Hospital Acquired Infections (HAIs), Cancer/Oncology, Prenatal/Neonatal Testing, and Other Applications By End-user– Clinics and Diagnostic Laboratories, Hospital Outpatient Departments and Intensive Care Units (ICUs), Research and Academic Institutes, and Other End Users |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, it has segmented the global P-o-c molecular diagnostic market report based on product & solution, technology, application, end-user, and region.
Global P-o-c Molecular Diagnostic Market, By Product & Solution:
- Kits & Assays
- Analyzers
- Software & Services
Global P-o-c Molecular Diagnostic Market, By Technology:
- PCR-based
- Genetic Sequencing-based
- Hybridization-based
- Microarray-based
Global P-o-c Molecular Diagnostic Market, By Application:
- Respiratory Diseases
- Sexually Transmitted Diseases (STDs)
- Hospital Acquired Infections (HAIs)
- Cancer/Oncology
- Prenatal/Neonatal Testing
- Other Applications
Global P-o-c Molecular Diagnostic Market, By End-user:
- Clinics and Diagnostic Laboratories
- Hospital Outpatient Departments and Intensive Care Units (ICUs)
- Research and Academic Institutes
- Other End Users
Global P-o-c Molecular Diagnostic Market, By Region:
- North America
-
-
- U.S.
- Canada
-
-
- Europe
-
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- Asia Pacific
-
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
-
- Latin America
-
-
- Brazil
- Mexico
- Rest of Latin America
-
-
- Middle East & Africa
-
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
-
Global P O C Molecular Diagnostic Market Key Players
The key players operating in the global p-o-c molecular diagnostic market include Abbott Laboratories, Bayer Healthcare, Cepheid, Inc., Becton, Dickinson and Company, BioMerieux, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Johnson and Johnson. Larger market participants involved in the target market are trying to strengthen their market positions by witnessing a phase of consolidation, amalgamation, and acquisitions. For instance, in March 2020, Abbott has received emergency use authorization (EUA) from the FDA for its molecular test for the identification of SARS-CoV-2, the virus that causes COVID-19. Tests already have been sent to the hospital and academic medical center labs in 18 states including Illinois, California, New York, Massachusetts, and Washington. Abbott is scaling up production at its U.S. manufacturing location to reach capacity for one million tests per week by end of March.
Global P O C Molecular Diagnostic Market Company Profile
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer Healthcare
- Cepheid, Inc.
- Becton, Dickinson and Company
- BioMerieux
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Johnson and Johnson
“*” marked represents similar segmentation in other categories in the respective section
Global P O C Molecular Diagnostic Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for P-o-c Molecular Diagnostic Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product & Solution
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End-user
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global P-o-c Molecular Diagnostic Market, By Product & Solution, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Kits & Assays
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Analyzers
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Software & Services
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global P-o-c Molecular Diagnostic Market, By Technology, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- PCR-based
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Genetic Sequencing-based
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Hybridization-based
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Microarray-based
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global P-o-c Molecular Diagnostic Market, By Application, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Respiratory Diseases
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Sexually Transmitted Diseases (STDs)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Hospital Acquired Infections (HAIs)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Cancer/Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Prenatal/Neonatal Testing
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Other Application
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global P-o-c Molecular Diagnostic Market, By End-user, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Clinics and Diagnostic Laboratories
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Hospital Outpatient Departments and Intensive Care Units (ICUs)
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Research and Academic Institutes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Other End Users
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global P-o-c Molecular Diagnostic Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 – 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product & Solution, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product & Solution, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product & Solution, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product & Solution, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product & Solution, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Technology, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Application, 2019 – 2029
- Market Size and Forecast (US$ Mn), By End-user, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Business Strategies
- Bayer Healthcare
- Cepheid, Inc.
- Becton, Dickinson and Company
- BioMerieux
- F. Hoffmann-La Roche AG
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Johnson and Johnson
- Abbott Laboratories
-
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The P-o-c Molecular Diagnostic Market report segments based on the basis of product & solution, technology, application, end-user, and region.
This is attributed to the growing number of cancer risk factors, lack of detection & treatment solutions, and lack of information about their causes.
Asia Pacific region is projected to grow at the fastest CAGR in the mentioned forecast period.
The leading players operating in the P-o-c Molecular Diagnostic Market include Abbott Laboratories, Bayer Healthcare, Cepheid, Inc., Becton, Dickinson and Company, BioMerieux, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and Johnson and Johnson.